Lv11
6 积分 2023-12-11 加入
Risk of Exacerbation and Level of Healthcare Resource Utilization in Myasthenia Gravis Assessed by Myasthenia Gravis Activities of Daily Living Score
3小时前
待确认
Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trial
3小时前
待确认
Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial
4小时前
已完结
A new pragmatic classification system for thymoma-associated myasthenia gravis: a retrospective cohort study
4小时前
已完结
Emerging drugs for the acute treatment of relapses in adult neuromyelitis optica spectrum disorder patients
14天前
已完结
Individualized regimen of low-dose rituximab monotherapy for new-onset AChR-positive generalized myasthenia gravis
17天前
已完结
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
1个月前
已完结
Pancreaticobiliary maljunction and congenital biliary dilatation
1个月前
已完结
Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy
1个月前
已完结
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD
1个月前
已完结
皖公网安备34019202002308
